Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · Real-Time Price · USD

12.97

+0.37 (2.94%)

Nov 17, 2025, 2:01 PM EST - Market open

RGC Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Nov '25 Nov 17, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2019 - 2020
Market Capitalization	6,414	8,426	44	300	450	-	Upgrade
Market Cap Growth	7032.57%	19171.44%	-85.42%	-33.42%	-	-	Upgrade
Enterprise Value	6,310	8,418	39	284	452	-	Upgrade
Last Close Price	12.60	17.04	0.09	0.61	0.91	-	Upgrade
PB Ratio	1299.23	1733.67	5.32	25.01	26.36	-	Upgrade
P/TBV Ratio	1299.23	1733.67	5.32	24.92	26.39	-	Upgrade
Debt / Equity Ratio	0.11	0.11	0.01	0.04	0.05	-0.92	Upgrade
Quick Ratio	7.38	7.38	41.13	19.06	28.42	0.01	Upgrade
Current Ratio	7.39	7.39	41.92	19.15	28.46	0.02	Upgrade
Return on Equity (ROE)	-54.81%	-54.81%	-43.18%	-41.71%	-116.10%	-	Upgrade
Return on Assets (ROA)	-33.20%	-33.20%	-28.11%	-25.59%	-51.87%	-202.15%	Upgrade
Return on Capital (ROIC)	-34.38%	-34.38%	-28.52%	-25.88%	-54.30%	-1670.73%	Upgrade
Earnings Yield	-0.06%	-0.04%	-9.84%	-1.96%	-1.65%	-	Upgrade
FCF Yield	-0.05%	-0.04%	-9.16%	-1.66%	-1.34%	-	Upgrade
Buyback Yield / Dilution	-	-	-	-1.62%	-28.06%	-	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q